Haleos Labs Limited (NSE:HALEOSLABS)
India · Delayed Price · Currency is INR 1,236.00
+1.40 (0.11%)
Jan 22, 2026, 10:36 AM IST
Haleos Labs Market Cap
Haleos Labs has a market cap or net worth of 3.73 billion as of January 21, 2026. Its market cap has increased by 1.28% in one year.
Market Cap
3.73B
Enterprise Value
4.58B
Revenue
3.38B
Ranking
n/a
PE Ratio
19.96
Stock Price
1,236.00
Market Cap Chart
Since August 17, 2017, Haleos Labs's market cap has increased from 407.69M to 3.73B, an increase of 815.54%. That is a compound annual growth rate of 30.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 3.73B | -6.75% |
| Dec 31, 2025 | 4.00B | 12.59% |
| Dec 31, 2024 | 3.56B | 122.05% |
| Dec 29, 2023 | 1.60B | -15.33% |
| Dec 30, 2022 | 1.89B | -14.48% |
| Dec 31, 2021 | 2.21B | 11.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Aug 17, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.02T |
| Divi's Laboratories | 1.66T |
| Cipla | 1.12T |
| Apollo Hospitals Enterprise | 1.03T |
| Mankind Pharma | 898.02B |
| Zydus Lifesciences | 873.51B |
| Alkem Laboratories | 697.84B |
| Aurobindo Pharma | 681.11B |